About

Solid IO is a Helsinki-based medtech startup transforming oncology and immunotherapy with next-generation organ-on-chip technology. It develops a patient-specific tumor-on-chip platform that replicates a patient's tumor and immune environment inside a chip to help develop new immunotherapies faster and more cheaply. Founded in January 2025, it secured roughly EUR 800k in early funding and a EUR 400,000 R&D grant from Business Finland. (Note: batch metadata listed the sector as Infra SaaS, but the identified company is biotech/healthtech.)

Latest news